← Back to Search

Ultrasound Therapy

Splenic Ultrasound for Rheumatoid Arthritis (ULTRA Trial)

N/A
Waitlist Available
Led By Erik Peterson, M.D.
Research Sponsored by SecondWave Systems Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study participation
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a new treatment for Rheumatoid Arthritis using a small device that sends sound waves to the spleen to reduce inflammation. It targets patients who suffer from chronic inflammation and may not respond well to typical treatments. The sound waves are safe and painless, helping to lower inflammation markers in the blood.

Eligible Conditions
  • Rheumatoid Arthritis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~8 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 8 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Within-arm change in the Disease Activity Score (DAS-28-CRP) from baseline to the completion of an up-to 8-week treatment period.
Other study objectives
Exit interview questions.
Within-arm change on the EQ-5D health questionnaire.
Within-arm change on the Multidimensional Health Assessment Questionnaire (HAQ).

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Ultrasound GroupExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Splenic Ultrasound
2021
N/A
~80

Find a Location

Who is running the clinical trial?

SecondWave Systems Inc.Lead Sponsor
3 Previous Clinical Trials
113 Total Patients Enrolled
University of MinnesotaOTHER
1,434 Previous Clinical Trials
1,621,629 Total Patients Enrolled
2 Trials studying Rheumatoid Arthritis
1,767 Patients Enrolled for Rheumatoid Arthritis
DARPA (United States Department of Defense)UNKNOWN
1 Previous Clinical Trials
58 Total Patients Enrolled

Media Library

Splenic Ultrasound (Ultrasound Therapy) Clinical Trial Eligibility Overview. Trial Name: NCT05417854 — N/A
Rheumatoid Arthritis Research Study Groups: Ultrasound Group
Rheumatoid Arthritis Clinical Trial 2023: Splenic Ultrasound Highlights & Side Effects. Trial Name: NCT05417854 — N/A
Splenic Ultrasound (Ultrasound Therapy) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05417854 — N/A
Rheumatoid Arthritis Patient Testimony for trial: Trial Name: NCT05417854 — N/A
~4 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top